» Articles » PMID: 14982877

Thymosin Alpha 1 Activates Dendritic Cells for Antifungal Th1 Resistance Through Toll-like Receptor Signaling

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2004 Feb 26
PMID 14982877
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DCs) show a remarkable functional plasticity in the recognition of Aspergillus fumigatus and orchestrate the antifungal immune resistance in the lungs. Here, we show that thymosin alpha 1, a naturally occurring thymic peptide, induces functional maturation and interleukin-12 production by fungus-pulsed DCs through the p38 mitogen-activated protein kinase/nuclear factor (NF)-kappaB-dependent pathway. This occurs by signaling through the myeloid differentiation factor 88-dependent pathway, involving distinct Toll-like receptors. In vivo, the synthetic peptide activates T-helper (Th) cell 1-dependent antifungal immunity, accelerates myeloid cell recovery, and protects highly susceptible mice that received hematopoietic transplants from aspergillosis. By revealing the unexpected activity of an old molecule, our finding provides the rationale for its therapeutic utility and qualify the synthetic peptide as a candidate adjuvant promoting the coordinated activation of the innate and adaptive Th immunity to the fungus.

Citing Articles

The efficacy and safety of thymosin α1 for sepsis (TESTS): multicentre, double blinded, randomised, placebo controlled, phase 3 trial.

Wu J, Pei F, Zhou L, Li W, Sun R, Li Y BMJ. 2025; 388:e082583.

PMID: 39814420 PMC: 11780596. DOI: 10.1136/bmj-2024-082583.


Thymus in Cardiometabolic Impairments and Atherosclerosis: Not a Silent Player?.

Kologrivova I, Naryzhnaya N, Suslova T Biomedicines. 2024; 12(7).

PMID: 39061983 PMC: 11273826. DOI: 10.3390/biomedicines12071408.


Phenotypic drug discovery: a case for thymosin alpha-1.

Garaci E, Paci M, Matteucci C, Costantini C, Puccetti P, Romani L Front Med (Lausanne). 2024; 11:1388959.

PMID: 38903817 PMC: 11187271. DOI: 10.3389/fmed.2024.1388959.


Dysregulated dendritic cells in sepsis: functional impairment and regulated cell death.

Zheng L, Duan Y, He P, Wu M, Wei S, Du X Cell Mol Biol Lett. 2024; 29(1):81.

PMID: 38816685 PMC: 11140885. DOI: 10.1186/s11658-024-00602-9.


Evaluation of the efficacy and safety of a precise thymalfasin-regulated PRaG regimen for advanced refractory solid tumours: protocol for the open-label, prospective, multicentre study (PRaG5.0 study).

Kong Y, Chen R, Xu M, Zhang J, Chen G, Hong Z BMJ Open. 2024; 14(3):e075642.

PMID: 38458816 PMC: 10928769. DOI: 10.1136/bmjopen-2023-075642.